114 related articles for article (PubMed ID: 10850345)
21. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.
Masson D; Denis MG; Denis M; Blanchard D; Loirat MJ; Cassagnau E; Lustenberger P
Br J Cancer; 1999 Aug; 80(12):1995-2000. PubMed ID: 10471052
[TBL] [Abstract][Full Text] [Related]
22. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
[TBL] [Abstract][Full Text] [Related]
23. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Iseki Y; Ikeya T; Sugano K; Hirakawa K
World J Surg Oncol; 2015 Jun; 13():194. PubMed ID: 26040932
[TBL] [Abstract][Full Text] [Related]
25. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
26. Assessment of activity of an adhesion molecule CD134 and CD137 in colorectal cancer patients.
Cepowicz D; Gryko M; Zaręba K; Stasiak-Bermuta A; Kędra B
Pol Przegl Chir; 2011 Dec; 83(12):641-5. PubMed ID: 22343199
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
28. In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression.
Shimazaki J; Goto Y; Nishida K; Tabuchi T; Motohashi G; Ubukata H; Tabuchi T
Oncology; 2013; 84(6):356-61. PubMed ID: 23689116
[TBL] [Abstract][Full Text] [Related]
29. CEA as a prognostic factor in colorectal cancer.
Filella X; Molina R; Piqué JM; Grau JJ; Garcia-Valdecasas JC; Biete A; Novell F; Astudillo E; Bordas JM; Campo E
Anticancer Res; 1994; 14(2B):705-8. PubMed ID: 8010730
[TBL] [Abstract][Full Text] [Related]
30. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic criteria and risk groups in colorectal cancer].
Mentges B; Brückner R
Wien Med Wochenschr; 1988 Jul; 138(13):317-22. PubMed ID: 3188544
[TBL] [Abstract][Full Text] [Related]
32. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
[TBL] [Abstract][Full Text] [Related]
33. The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer.
Pellegrini P; Berghella AM; Contasta I; Del Beato T; Adorno D
Cancer Biother Radiopharm; 2006 Oct; 21(5):443-67. PubMed ID: 17105419
[TBL] [Abstract][Full Text] [Related]
34. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of HLA class I expression in patients with colorectal cancer.
Iwayama Y; Tsuruma T; Mizuguchi T; Furuhata T; Toyota N; Matsumura M; Torigoe T; Sato N; Hirata K
World J Surg Oncol; 2015 Feb; 13():36. PubMed ID: 25889416
[TBL] [Abstract][Full Text] [Related]
38. Immunological directives for biotherapy improvement in the treatment of colorectal cancer.
Pellegrini P; Berghella AM; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Apr; 11(2):113-8. PubMed ID: 10851527
[TBL] [Abstract][Full Text] [Related]
39. The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer Patients.
Lin HH; Yang HL; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Chen WS; Liang WY; Chang SC
Hepatogastroenterology; 2014 Jun; 61(132):1024-7. PubMed ID: 26158160
[TBL] [Abstract][Full Text] [Related]
40. The effect of colorectal cancer upon host peripheral immune cell function.
Evans CF; Galustian C; Bodman-Smith M; Dalgleish AG; Kumar D
Colorectal Dis; 2010 Jun; 12(6):561-9. PubMed ID: 19250260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
